Opinion|Videos|October 14, 2023

Tazemetostat: Targeting EZH2 in R/R Follicular Lymphoma

Hematologist/oncologists describe the rationale for treatment approaches targeting EZH2 and discuss recent guideline updates surrounding the role of tazemetostat and EZH2 testing in patients with follicular lymphoma.


Latest CME